CN · Field Sheet
FIELD SHEET — LEMON BALM MFI-LEMBAL-20261023-FS
Survey index / LEMON BALM

Lemon Balm.

Melissa officinalis
Melissa leaf; calm, sleep-onset and gastrointestinal literature.
SEALED MFI-LEMBAL-20261023-FS · RELEASED 2026-10-23
SHEET FINGERPRINTMFI-LEMBAL-20261023-FS
160INCLUDED
1,592EXCLUDED
21DUPLICATE
73NON-TRANSFERABLE
2OUT OF CUTOFF
Survey totalsScroll ↓
1,848records surveyed
160studies
22claims graded
85observations
6,055graph nodes

Claim records

2 shown · bounded preview
RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-abe2a2e87b755b1fGRADE VERY_LOW
lemon balm constituents — antioxidant
direction BENEFIT · dose UNSPECIFIED · duration 42 days
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
LOWextraction
VERY_LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
5bound studies
Bound studies (4 shown of 5)
STU-37ef9d2d45e773c2
IN_VITRO · IN_VITRO · 2012 · RoB INSUFFICIENT_INFORMATION
4 endpoints
STU-940afa5c55e62c82
IN_VITRO · IN_VITRO · 2013 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-a93833c8e551f28b
ANIMAL · ANIMAL · 2025 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-d96ca7a55bd8faef
ANIMAL · ANIMAL · 2012 · 42 days · RoB SOME_CONCERNS
3 endpoints
Quantitative observations
observation 42 days · failed extraction
observation p < 0.001 | p < 0.05 · failed extraction
observation p < 0.05 | p < 0.05 · failed extraction
Opposition screen
SCREEN · 10 candidates considered · 3 bound as opposing
SYNTHESIS SYN-6a59c6d3e674a2 — outcome QUALITATIVE_ONLY · BENEFIT ×5 · not_assessed_quantitatively · 5 members
PROVENANCE → oax:https://openalex.org/W135074436, oax:https://openalex.org/W2331383272, epmc:40470741 · PKG 9ee2273d9eb29c39…
CLAIM · CLM-284204357ded0023GRADE LOW
lemon balm constituents — sleep
direction BENEFIT · dose 200 mg; 320 mg · duration 2 week
Grade basis — weakest-link ceilings
MODERATEdesign
LOWdirectness
MODERATEextraction
LOWconfidence
LOWmethodology
MODERATEconsistency
MODERATEnumeric
3bound studies
Bound studies (3 shown of 3)
STU-2246950f9ac12df1
COHORT · HUMAN · 2014 · RoB INSUFFICIENT_INFORMATION
1 endpoints
STU-47cea354f8501d3e
TRIAL · HUMAN · 2024 · RoB HIGH_RISK
2 endpoints
STU-4fe9d5f43451850c
TRIAL · HUMAN · 2019 · 2 week · RoB HIGH_RISK
1 endpoints
Quantitative observations
observation 200 mg · validated
observation 40 · validated
observation p < 0.001 | p < 0.01 · failed extraction
Opposition screen
SCREEN · 3 candidates considered · 0 bound as opposing
SYNTHESIS SYN-f244f35ff005af — outcome QUALITATIVE_ONLY · BENEFIT ×3 · not_assessed_quantitatively · 3 members
PROVENANCE → epmc:24837472, epmc:39174857, epmc:31331545 · PKG 9ee2273d9eb29c39…
Bounded preview — representative records only. The full release ships 22 claims and 85 observations.